Company intelligence / Profile preview

Brainware AI

Ottawa, Ontario, Canadabrainwareai.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Brainware AI has developed a real-time system that calculates and tracks acute and chronic brain trauma levels using only 2D video. The platform is designed to provide actionable data for athlete safety but has not yet reported clinical trial results or commercial deployment as of mid-2025[1][2].

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapy (real-time brain trauma monitoring via video analytics)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Brainware AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brainware AI.

Explore the full profile